Nancy Whiting is the founder of Recludix Pharma. Recludix Pharma has raised $60M in total funding. Latest round: Series A. Based in San Diego, CA.
Nancy Whiting, Pharm.D., is the CEO of Recludix Pharma, a biotechnology company focused on discovering therapies for cancer and inflammatory diseases. She was appointed as chief executive officer when Recludix launched in November 2021 with a $60 million Series A round. Whiting previously served as a 15-year executive at Seagen before joining Recludix as its CEO.
Full founder directory · Investor directory · Company funding database · Fundraising library